These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37846574)

  • 1. Evidence-based management of optic neuritis.
    Bergeron E; Bouffard MA
    Curr Opin Ophthalmol; 2024 Jan; 35(1):73-82. PubMed ID: 37846574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of first-onset optic neuritis based on diagnostic criteria and antibody status: a multicentre analysis of 427 eyes.
    Min YG; Moon Y; Kwon YN; Lee BJ; Park KA; Han JY; Han J; Lee HJ; Baek SH; Kim BJ; Kim JS; Park KS; Kim NH; Kim M; Nam TS; Oh SI; Jung JH; Sung JJ; Jang MJ; Kim SJ; Kim SM
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):753-760. PubMed ID: 38418215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
    Wildemann B; Horstmann S; Korporal-Kuhnke M; Viehöver A; Jarius S
    Klin Monbl Augenheilkd; 2020 Nov; 237(11):1290-1305. PubMed ID: 33202462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT].
    Almer Z
    Harefuah; 2022 Oct; 161(10):645-651. PubMed ID: 36315205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore.
    Foo R; Yau C; Singhal S; Tow S; Loo JL; Tan K; Milea D
    Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):184-195. PubMed ID: 35533337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis: current challenges in diagnosis and management.
    Benard-Seguin E; Costello F
    Curr Opin Neurol; 2023 Feb; 36(1):10-18. PubMed ID: 36630210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Treatment of Acute Optic Neuritis.
    Keyhanian K; Chwalisz BK
    Semin Ophthalmol; 2023 Aug; 38(6):511-514. PubMed ID: 37162276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
    Stiebel-Kalish H; Rubarth K; Shouchane-Blum K; Tiosano A; Lotan I; Hellmann MA; Wilf-Yarkoni A; Bialer O; Flanagan EP; Pittock SJ; Bhatti MT; Schmitz-Hübsch T; Paul F; Asseyer S; Chen JJ
    Sci Rep; 2022 Dec; 12(1):21312. PubMed ID: 36494385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
    Moheb N; Chen JJ
    Eye (Lond); 2023 Aug; 37(12):2391-2398. PubMed ID: 36928226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
    Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
    Eur J Neurol; 2022 Mar; 29(3):802-809. PubMed ID: 34799965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on optic neuritis.
    Kraker JA; Chen JJ
    J Neurol; 2023 Oct; 270(10):5113-5126. PubMed ID: 37542657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Typical and atypical optic neuritis].
    Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
    Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
    Gospe SM; Chen JJ; Bhatti MT
    Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Course and Treatment Response of Neuromyelitis Optica Spectrum Disease: An 8-Year Experience.
    Lin CW; Lin IH; Chen TC; Jou JR; Woung LC
    Asia Pac J Ophthalmol (Phila); 2019; 8(3):206-210. PubMed ID: 30421588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management].
    Rodríguez-Acevedo B; Rovira A; Vidal-Jordana A; Moncho D; Pareto D; Sastre-Garriga J
    Rev Neurol; 2022 Feb; 74(3):93-104. PubMed ID: 35084734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
    Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis.
    Saitakis G; Chwalisz BK
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.